Skip to main content Skip to main navigation menu Skip to site footer

The management of ovarian cancer in pregnancy: a rare case report

  • Dewangga Wahyu Praja ,
  • Primandono Perbowo ,

Abstract

Link of Video Abstract: https://youtu.be/gGzNJpCiosc

 

Introduction: Ovarian tumors are found in approximately 1 in 1000 pregnancies. The simultaneous management of three separate yet interconnected entities: the mother, the fetus, and the disease complicates cancer care during pregnancy. The treatment of a pregnant woman with ovarian cancer is described in this paper.

Case Presentation: A 24-year-old pregnant lady (G2P0A1, 24 weeks gestational age, [GA]) was brought to our hospital after a routine prenatal ultrasound revealed a 15x18 cm left adnexal tumor. We discovered the complex adnexal mass, which was approximately 20x13.3x16 cm in size, in the left ovary, producing severe bilateral hydronephrosis on magnetic resonance imaging (MRI). The laboratory tests performed were within normal limits except for higher serum lactate dehydrogenase levels. At 34 weeks GA, the pregnancy was terminated via cesarean section. The baby (female, 1,600 g) was born alive with no congenital defects and an Apgar score of 3-5-7. Following that, a unilateral salpingo-oophorectomy was performed.  Pathology indicated a high-grade serous carcinoma of the left ovary with positive ascites fluid but no evidence of metastases to the pelvic lymph nodes, omentum, or peritoneum (stage IC). We had planned to treat the woman with a paclitaxel-carboplatin combination, but she declined because she preferred to breastfeed her infant. She had no abdominal issues at 15 months and was still breastfeeding the baby.

Conclusion: Pregnancy-related epithelial ovarian cancer is uncommon but is a possibility. Clinical findings, diagnostic, and treatment strategies are roughly similar to non-pregnant patients, except for the timing of chemotherapy initiation. Further research is needed to give evidence regarding these mother-infant dyads' survival and health outcomes.

References

  1. Mulawardhana P, Hartono P, Nugroho H, Ayuningtyas A. Death of 43 indonesian women with ovarian cancer: A case series. Int J Surg Case Rep. 2021;78:391-6.
  2. Franciszek Dłuski D, Mierzyński R, Poniedziałek-Czajkowska E, Leszczyńska-Gorzelak B. Ovarian cancer and pregnancy-a current problem in perinatal medicine: A comprehensive review. Cancers (Basel). 2020;12(12).
  3. Hummeida ME, Hamad K, Gadir AF, Ali AA. Ovarian cancer during pregnancy: A case report and literature review. Clin Pract. 2015;5(2):727.
  4. Pei Y, Gou Y, Li N, Yang X, Han X, Huiling L. Efficacy and safety of platinum-based chemotherapy for ovarian cancer during pregnancy: A systematic review and meta-analysis. Oncol Ther. 2022;10(1):55-73.
  5. Fruscio R, de Haan J, Van Calsteren K, Verheecke M, Mhallem M, Amant F. Ovarian cancer in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2017;41:108-17.
  6. Michalczyk K, Cymbaluk-Płoska A. Approaches to the diagnosis and management of ovarian cancer in pregnancy. Cancer Manag Res. 2021;13:2329-39.
  7. Amant F, Berveiller P, Boere IA, Cardonick E, Fruscio R, Fumagalli M, et al. Gynecologic cancers in pregnancy: Guidelines based on a third international consensus meeting. Ann Oncol. 2019;30(10):1601-12.
  8. Puentes O, Quijano T, Mora E, Rojas C. Ep1285 pregnancy and epithelial ovarian cancer: Case report. International Journal of Gynecologic Cancer. 2019;29(Suppl 4):A647.
  9. Mukhopadhyay A, Shinde A, Naik R. Ovarian cysts and cancer in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2016;33:58-72.
  10. Korenaga TK, Tewari KS. Gynecologic cancer in pregnancy. Gynecol Oncol. 2020;157(3):799-809.
  11. Singh N, McCluggage WG, Gilks CB. High-grade serous carcinoma of tubo-ovarian origin: Recent developments. Histopathology. 2017;71(3):339-56.
  12. Gockley A, Melamed A, Bregar AJ, Clemmer JT, Birrer M, Schorge JO, et al. Outcomes of women with high-grade and low-grade advanced-stage serous epithelial ovarian cancer. Obstet Gynecol. 2017;129(3):439-47.
  13. Xing N, Wang L, Sui X, Zhao C, Huang Y, Peng J. The safety of chemotherapy for ovarian malignancy during pregnancy. J Clin Med. 2022;11(24).
  14. Griffin SJ, Milla M, Baker TE, Liu T, Wang H, Hale TW. Transfer of carboplatin and paclitaxel into breast milk. J Hum Lact. 2012;28(4):457-9.
  15. Jackson C, Morris T, Hung N, Hung T. Breast milk paclitaxel excretion following intravenous chemotherapy-a case report. Br J Cancer. 2019;121(5):421-4.

How to Cite

Praja, D. W., & Primandono Perbowo. (2024). The management of ovarian cancer in pregnancy: a rare case report. Bali Medical Journal, 13(2), 610–613. https://doi.org/10.15562/bmj.v13i2.4900

HTML
5

Total
2

Share

Search Panel

Dewangga Wahyu Praja
Google Scholar
Pubmed
BMJ Journal


Primandono Perbowo
Google Scholar
Pubmed
BMJ Journal